指南与共识间质性肺疾病

英国罕见囊性肺病协作网:囊性肺疾病诊断立场声明

Diagnosis of cystic lung diseases: a position statement from the UK Cystic Lung Disease Rare Disease Collaborative Network.
指南 / 共识 · Thorax · 2024-03-15

该立场声明由英国囊性肺病罕见病协作网制定,旨在综述如何利用临床、影像和生理特征鉴别罕见囊性肺疾病。声明强调多数病例可通过多学科诊断而无需肺活检,并建议对所有多发肺囊肿患者进行聚焦性检查以优化转诊路径和早期治疗。

要点

  • 多数囊性肺疾病可通过多学科评估诊断,无需肺活检。
  • 所有患者应行胸腹部CT、肺功能、气体交换和6分钟步行试验。
  • 外科肺活检前建议与罕见囊性肺病中心讨论。

核心结论

  • 聚焦性检查应适用于所有多发肺囊肿患者,以简化转诊路径、指导早期治疗并可能推动建立国家研究数据库。

研究设计与样本

  • 英国囊性肺病罕见病协作网制定的立场声明,基于临床、影像和生理特征综述鉴别诊断方法。

主要发现

  • 朗格汉斯细胞组织细胞增生症、Birt-Hogg-Dubé综合征、淋巴细胞性间质性肺炎和淋巴管肌瘤病是呼吸科医生较熟知的疾病。
  • 针对性的全面检查可提高诊断准确性,并可能提示其他极罕见疾病如轻链沉积病、囊性肺淀粉样变、低级别转移性肿瘤或感染。
  • 许多病例中诊断信息被忽视,导致疾病进程和治疗的不确定性。

关键数值与推荐

  • 所有患者应行胸部及腹部CT以明确肺囊肿模式和负荷及肺外特征。
  • 所有患者应行肺量计、气体交换和6分钟步行试验。
  • 外科肺活检前建议与罕见囊性肺病中心讨论。

临床怎么用

  • 对多发肺囊肿患者进行聚焦性检查,包括病史采集关注系统性和家族性疾病、体格检查寻找结缔组织病和遗传病因特征。
  • 通过多学科诊断避免不必要的肺活检,仅在非侵入性方法存疑时考虑组织采样。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rare cystic lung diseases are increasingly recognised due the wider application of CT scanning making cystic lung disease management a growing part of respiratory care. Cystic lung diseases tend to have extrapulmonary features that can both be diagnostic but also require surveillance and treatment in their own right. As some of these diseases now have specific treatments, making a precise diagnosis is crucial. While Langerhans cell histiocytosis, Birt-Hogg-Dubé syndrome, lymphoid interstitial pneumonia and lymphangioleiomyomatosis are becoming relatively well-known diseases to respiratory physicians, a targeted and thorough workup improves diagnostic accuracy and may suggest other ultrarare diseases such as light chain deposition disease, cystic pulmonary amyloidosis, low-grade metastatic neoplasms or infections. In many cases, diagnostic information is overlooked leaving uncertainty over the disease course and treatments. AIMS: This position statement from the Rare Disease Collaborative Network for cystic lung diseases will review how clinical, radiological and physiological features can be used to differentiate between these diseases. NARRATIVE: We highlight that in many cases a multidisciplinary diagnosis can be made without the need for lung biopsy and discuss where tissue sampling is necessary when non-invasive methods leave diagnostic doubt. We suggest an initial workup focusing on points in the history which identify key disease features, underlying systemic and familial diseases and a clinical examination to search for connective tissue disease and features of genetic causes of lung cysts. All patients should have a CT of the thorax and abdomen to characterise the pattern and burden of lung cysts and extrapulmonary features and also spirometry, gas transfer and a 6 min walk test. Discussion with a rare cystic lung disease centre is suggested before a surgical biopsy is undertaken. CONCLUSIONS: We suggest that this focused workup should be performed in all people with multiple lung cysts and would streamline referral pathways, help guide early treatment, management decisions, improve patient experience and reduce overall care costs. It could also potentially catalyse a national research database to describe these less well-understood and unidentified diseases, categorise disease phenotypes and outcomes, potentially leading to better prognostic data and generating a stronger platform to understand specific disease biology.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Johnson, Shaw, Avoseh, et al. Diagnosis of cystic lung diseases: a position statement from the UK Cystic Lung Disease Rare Disease Collaborative Network. Thorax. 2024. PMID: 38182428. doi:10.1136/thorax-2022-219738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。